Content reviewed by clinical research staff

Last reviewed: March 2026Sources: PubMed, FDA, WADA Prohibited List

Evidence graded using the PeptideScholar A-D system

Abaloparatide

AFDA Approved
65
Moderate Credibility
1 cited studyy · Evidence level A

Parathyroid hormone-related protein analog (1-34) · 34 amino acids · Brand: Tymlos

FDA ApprovedPrescription Required

Abaloparatide is a synthetic analog of parathyroid hormone-related protein (PTHrP 1-34) approved by the FDA for osteoporosis in postmenopausal women at high risk of fracture. Like teriparatide, it is an anabolic bone-building agent with a more transient receptor activation profile.

Mechanism of Action

Binds to PTH1 receptors on osteoblasts, stimulating bone formation. As a PTHrP analog with more transient receptor signaling, it preferentially activates bone formation over bone resorption in early treatment, potentially producing faster BMD increases with lower hypercalcemia risk.

Benefits

  • Anabolic bone-building agent for severe osteoporosis
  • Significant reduction in vertebral and non-vertebral fractures[1]
  • Faster early BMD gains than teriparatide in some studies
  • Lower incidence of hypercalcemia vs teriparatide
Not Medical Advice — Research-Reported Information Only

This content is for informational purposes only and does not constitute medical advice.

Abaloparatide — Dosing in Published Research

Reported Routes: Subcutaneous injection
80 mcg SC once daily into abdomen. Maximum lifetime duration: 2 years (same as teriparatide). Should be followed by an antiresorptive agent (bisphosphonate or denosumab) to maintain BMD gains.

The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.

Side Effects

  • Hypercalcemia (less frequent than teriparatide)
  • Dizziness, nausea, headache
  • Palpitations and orthostatic hypotension
  • Injection site reactions
  • Osteosarcoma risk in rats (black box warning; 2-year limit)

Ready to Discuss Abaloparatide with a Doctor?

Abaloparatide is FDA-approved and available by prescription. Licensed telehealth providers can evaluate if it's right for you.

Find a Prescribing Provider

Telehealth consultations available in most states

FDA ApprovedBoard-Certified DoctorsPrescription if Appropriate

PeptideScholar may receive compensation from provider referrals. This does not influence our editorial content.

Approved Treatment Routing

Abaloparatide in PeptideScholar's current approved-treatment dataset

Abaloparatide is currently modeled on this site as an approved treatment path for: Osteoporosis in postmenopausal women at high risk of fracture. Brand names in the current dataset: Tymlos.

Validation Note
This block reflects the site's current structured treatment data and internal routing logic. It is not a substitute for checking current prescribing, labeling, payer, or local regulatory details.

Research & Evidence

RCTJ Clin Endocrinol Metab, 2020

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.

Abaloparatide followed by alendronate significantly reduced vertebral fractures by 87% and non-vertebral fractures by 52% vs placebo/alendronate sequence over 3 years

PMID: 31674644

References

  1. 1. Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.. J Clin Endocrinol Metab, 2020. Abaloparatide followed by alendronate significantly reduced vertebral fractures by 87% and non-vertebral fractures by 52% vs placebo/alendronate sequence over 3 years [PMID: 31674644]

Recommended Resources

The Peptide Protocols Handbook

Evidence-based reference guide covering mechanisms, research, and clinical applications.

View on Amazon

Third-Party Peptide Testing

Independent lab analysis to verify peptide purity and authenticity.

Learn More

Links may be affiliate links. See our disclosure.

GLP-1 Support Essentials

Products to help manage side effects and optimize outcomes during treatment.

Amazon affiliate links — we may earn a small commission at no extra cost to you. See our disclosure.

Progress Tracking Tools

Monitor weight, body composition, and nutrition to maximize results.

Amazon affiliate links — we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links — we may earn a small commission at no extra cost to you. See our disclosure.

Abaloparatide FAQ

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.

Get peptide research updates

Weekly evidence summaries and regulatory alerts.

No spam. Unsubscribe anytime.